Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q3 2021 · 10-Q
Revenue—
Net Income-$3.72M-$3.72MN/M vs Q3 2020 EPS Diluted-$0.28-$0.28N/M vs Q3 2020 Operating Income-$3,499,000N/M Operating Cash Flowderived-$2,251,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,305,000N/M ended Sep 30, 2021 · filed Oct 21, 2021 · 21 d after period end